C. Stroszczynski et al., USE OF GA-67-SPECT IN PATIENTS WITH MALIG NANT-LYMPHOMA FOLLOWING PRIMARY CHEMOTHERAPY FOR FURTHER TREATMENT PLANNING - COMPARISON WITH SPIRAL CT, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 167(5), 1997, pp. 458-466
Citations number
34
Journal title
RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren
Purpose: To compare the diagnostic value of gallium scintigraphy using
a SPECT technique with spiral CT for evaluating activity following ch
emotherapy in patients with malignant lymphoma and to determine treatm
ent options. Material and Method: The results of gallium scintigraphy
in 28 patients with malignant lymphoma (19 Hodgkin's disease, 9 high g
rade non-Hodgkin's lymphoma) following curative treatment were compare
d with the CT morphology in relation to inactive regions and residual
masses. Results: Ga-67-SPECT proved superior to CT for evaluating the
activity in 85 initially involved nodes (sensitivity 94.4% against 83.
3%; specificity 100% against 92.5%). It was, however, inferior for dem
onstrating organ involvement in 28 instances. In seven patients with r
esidual masses, Ga-67-SPECT directly affected staging and further ther
apy. Conclusion: The increasing use of secondary treatment schemes for
curative purposes makes Ga-67-SPECT a suitable method for the early r
ecognition of residual activity in Hodgkin's disease and high grade no
n-Hodgkin's lymphoma.